folic acid has been researched along with Arteriosclerosis, Coronary in 127 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (1.57) | 18.7374 |
| 1990's | 8 (6.30) | 18.2507 |
| 2000's | 86 (67.72) | 29.6817 |
| 2010's | 25 (19.69) | 24.3611 |
| 2020's | 6 (4.72) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubowski, H; Perła-Kaján, J; Sikora, M; Skrzydlewski, P | 1 |
| Eun, YM; Kim, HN; Song, SW | 1 |
| Chen, H; Guo, H; He, M; He, S; Hu, FB; Jiang, J; Li, J; Liang, L; Liu, K; Liu, X; Long, P; Pan, A; Qiu, G; Wu, T; Xu, C; Yang, H; Yu, K; Yuan, Y; Zhang, X | 1 |
| Wu, PF; Zhang, R; Zhang, W; Zhang, X | 1 |
| Long, P; Pan, A | 1 |
| Indumathi, B; Kutala, VK; Naushad, SM; Oruganti, SS | 1 |
| Ahmadi, N; Budoff, MJ; Flores, F; Zeb, I | 1 |
| Dierkes, J; Gregory, JF; Nygård, O; Seifert, R | 1 |
| Hou, FF; Li, Y; Qin, X | 1 |
| Alrokayan, SA; Hussain, T; Indumathi, B; Kutala, VK; Naushad, SM; Samreen, K | 1 |
| Garg, MK; Kulkarni, MV; Mahalle, N; Naik, SS | 1 |
| Bleie, O; Borgeraas, H; Løland, KH; Nordrehaug, JE; Nygård, O; Strand, E; Svardal, A; Ueland, PM | 1 |
| Berge, RK; Bjørndal, B; Bohov, P; Hiltunen, JK; Meyer, K; Nilsen, DW; Nordrehaug, JE; Nygård, O; Pedersen, ER; Rebnord, EW; Schartum-Hansen, H; Seifert, R; Strand, E; Svingen, GF | 1 |
| Gao, L; Liu, Y; Tian, T; Zhang, H; Zhou, X | 1 |
| Das, UN | 1 |
| Chen, S; Chen, Z; Han, L; Liu, S; Ma, J; Peng, X; Wang, C; Zhao, D | 1 |
| Cha, DH; Jeon, YJ; Kim, IJ; Kim, JO; Kim, NK; Kim, OJ; Kim, SH; Lee, BE; Lim, SW; Moon, JY; Sung, JH | 1 |
| Chen, B; Cheng, F; Lan, J; Li, S; Pan, W; Tu, C; Xia, W | 1 |
| Schooling, CM; Zhao, JV | 1 |
| Huang, C; Liu, C; Luo, J; Ma, Y; Peng, D | 1 |
| Cheng, CH; Huang, MC; Huang, YC; Lee, BJ; Lin, PT; Tsai, TP | 1 |
| Bleie, Ø; Ebbing, M; Nilsen, DW; Nordrehaug, JE; Nygård, O; Pedersen, EK; Refsum, H; Ueland, PM; Vollset, SE | 1 |
| Cucchiara, AJ; Hammons, AL; Mohr, E; Nackos, E; Summers, CM; Von Feldt, JM; Whitehead, AS | 1 |
| Antoniades, C; Antonopoulos, AS; Marinou, K; Stefanadis, C; Tousoulis, D | 1 |
| Altinbaş, A; Demir, M; Doğan, A; Ozaydin, M; Varol, E | 1 |
| Aydin, M; Gokkusu, C; Ozbek, Z; Ozkok, E; Pamukcu, B; Tulubas, F; Umman, B; Unlucerci, Y | 1 |
| Lundberg, GD | 1 |
| Biselli, PM; Carvalho, VM; de Godoy, MF; Eberlin, MN; Goloni-Bertollo, EM; Guerzoni, AR; Haddad, R; Pavarino-Bertelli, EC; Vannucchi, H | 1 |
| Elbaz, M; Roncalli, J | 1 |
| Daubert, JC; Froger-Bompas, C; Guillo, P; Laviolle, B; Letellier, C; Ligier, K; Paillard, F | 1 |
| Alekel, DL; Crist, BL; Genschel, U; Hanson, LN; Reddy, MB; Ritland, LM | 1 |
| Böhm, BO; Fuchs, D; Grammer, T; März, W; Meinitzer, A; Murr, C; Schroecksnadel, K | 1 |
| Assali, A; Battler, A; Hasdai, D; Koren-Morag, N; Kornowski, R; Lev, IE; Mager, A; Orvin, K; Shohat, M | 1 |
| Boehm, BO; Fuchs, D; Grammer, TB; März, W; Schroecksnadel, K | 1 |
| Bleie, O; Blix, AJ; Ebbing, M; Løland, KH; Nordrehaug, JE; Nygård, O; Refsum, H; Strand, E; Ueland, PM | 1 |
| Ardic, I; Celik, A; Ceyhan, K; Erdem, S; Kadi, H; Kalay, N; Kaya, MG; Koc, F; Onalan, O; Ozbek, K; Sahin, S; Taner, A; Yarlioglues, M | 1 |
| Bleie, Ø; Igland, J; Nordrehaug, JE; Nygård, OK; Refsum, H; Strand, E; Ueland, PM; Vollset, SE | 1 |
| Masud, R; Qureshi, IZ | 1 |
| Lele, SS; Mukherjee, MS; Singh, PR | 1 |
| Addlagatta, A; Digumarti, RR; Divyya, S; Gottumukkala, SR; Kumar, A; Kutala, VK; Murthy, PV; Naushad, SM; Rammurti, S; Reddy, ChR | 1 |
| Lele, SS; Singh, PR | 1 |
| Dhall, A; Garg, S; Gupta, SK; Kotwal, A; Kotwal, J | 1 |
| Kotamraju, S; Kutala, VK; Lakshmi, SV; Naushad, SM; Rao, DS; Reddy, CA; Saumya, K | 1 |
| Beaty, TH; Jee, SH; Kim, HK; Park, JY; Shim, WH; Song, KS; Suh, I; Won, SY | 1 |
| Anderson, JL; Bair, TL; Carlquist, JF; Habashi, J; Hart, NI; Horne, BD; Jones, SK; Muhlestein, JB | 1 |
| Karikas, GA; Papakonstantinou, E; Schulpis, KH | 1 |
| Hu, FB; Willett, WC | 1 |
| Diaz-Arrastia, R; Frol, AB; Rogers, JD; Sanchez-Saffon, A | 1 |
| Corrocher, R; Faccini, G; Friso, S; Girelli, D; Martinelli, N; Olivieri, O; Pignatti, PF; Pizzolo, F; Stranieri, C; Tinazzi, E; Trabetti, E | 1 |
| Baumgartner, RN; Garry, PJ; Koehler, KM; Lindeman, RD; Romero, LJ; Yau, CL | 1 |
| Jukema, JW; Liem, A; Reynierse-Buitenwerf, GH; van Veldhuisen, DJ; Zwinderman, AH | 1 |
| Aro, A | 1 |
| BOBKOVA, VI | 1 |
| Aranda, JM; Cleeton, TS; Hill, JA; Schofield, RS; Walker, TC; Wessel, TR | 1 |
| Chotkowska, E; Dzielińska, Z; Gaździk, D; Janas, J; Kadziela, J; Piotrowski, W; Ruzyłło, W; Szperl, M | 1 |
| Braun, S; Burghartz, M; Kastrati, A; Koch, W; Kölling, K; Lengnick, H; Mehilli, J; Ndrepepa, G; Schömig, A | 1 |
| Grégoire, J; L'Allier, PL; Lavoie, MA; Tardif, JC | 1 |
| Bertrais, S; Castetbon, K; de Bree, A; Galan, P; Hercberg, S; Mennen, L; Potier de Courcy, G; Preziozi, P | 1 |
| Gill, JM; Hale, W; Hecox, K; Mackler, L | 1 |
| Aengevaeren, WR; Blom, HJ; Boers, GH; Verheugt, FW; Willems, FF | 1 |
| Rauwerda, JA; Stehouwer, CD; Twisk, JW; van Campen, CM; van Engeland, MI; Vermeulen, EG; Visser, FC | 1 |
| Cheng, CH; Chung, LJ; Huang, MC; Huang, YC; Lee, BJ; Lin, KL; Su, KH | 1 |
| Cheng, J; Guo, H; Lee, JD; Shan, J; Ueda, T; Wang, J | 1 |
| Braun, S; Kastrati, A; Koch, W; Kölling, K; Mehilli, J; Ndrepepa, G; Schömig, A | 2 |
| Kowalska, I; Lewczuk, A; Mroczko, B; Musiał, W; Prokop, J; Sawicki, R; Skibińska, E | 1 |
| Cheng, J; Geshi, T; Guo, H; Lee, JD; Toyoda, K; Ueda, T; Xing, Y | 1 |
| Alpert, NM; Aziz, KS; Fischman, AJ; Gewirtz, H; Holmvang, G; Migrino, RQ; Muller, JE; Tawakol, A; Waitkowska, J | 1 |
| Chi, HS; Huh, HJ; Jang, S; Park, CJ; Shim, EH | 1 |
| Gottsäter, A; Hultberg, B; Jonasson, T; Ohlin, AK; Ohlin, H | 1 |
| Basar, N; Bicer, A; Erbay, AR; Sahin, O; Turhan, H; Yasar, AS; Yetkin, E | 1 |
| Bukowska, H; Honczarenko, K; Jastrzebska, M; Mierzecki, A; Millo, B; Torbus-Lisiecka, B | 1 |
| Bowron, A; Scott, J; Stansbie, D | 1 |
| Adjalla, CE; Candito, M; Gibelin, P; Gueánt, JL; Guéant-Rodriguez, RM; Herbeth, B; Juilliére, Y; Van Obberghen, E | 1 |
| Chan, JB; Chen, CP; Eikelboom, JW; Hankey, GJ; Ho, GY; Tan, SL; Wong, CR | 1 |
| Brozek, J; Jakubowski, H; Jankowski, M; Siudak, Z; Szczeklik, A; Undas, A | 1 |
| Burlina, A; Cesari, M; Maiolino, G; Pedon, L; Pessina, AC; Rossi, GP; Seccia, TM; Sticchi, D; Zanchetta, M; Zavattiero, S | 1 |
| Buysschaert, M; Gala, JL; Hermans, MP | 1 |
| Enli, Y; Evrengul, H; Kaftan, A; Kilic, M; Kuru, O; Seleci, D; Tanriverdi, H; Tanriverdi, S | 1 |
| Gazdzik, D; Janas, J; Pajak, A; Rywik, S; Sygnowska, E; Waśkiewicz, A | 1 |
| Darvish, S; Davoodi, G; Fallah, N; Fallahi, F; Karimi, A; Mahmoodian, M; Sadeghian, S; Salarifar, M | 1 |
| Alekel, DL; Engelman, HM; Hanson, LN; Kohut, ML; Reddy, MB; Schalinske, KL | 1 |
| Appel, LJ; Bleys, J; Guallar, E; Miller, ER; Pastor-Barriuso, R | 1 |
| Allen, RH; Goodfellow, J; Lang, D; Lewis, MJ; Madhavan, A; McDowell, IF; Moat, SJ; Payne, N; Stabler, SP; Taylor, SY | 1 |
| Głuszek, J; Pawlak, AL; Strauss, E; Supiński, W | 1 |
| Antoniades, C; Channon, KM; Francis, JM; Jackson, CE; Lee, J; Moat, SJ; Neubauer, S; Pillai, R; Ratnatunga, C; Refsum, H; Robson, MD; Shirodaria, C | 1 |
| Bakken, AM; Bleie, Ø; Grundt, H; Nilsen, DW; Nordrehaug, JE; Nygård, OK; Refsum, H; Semb, AG; Ueland, PM; Vollset, SE | 1 |
| Blum, A; Blum, N; Eizenberg, MM; Hijazi, I | 1 |
| Wenger, NK | 1 |
| Chatzikyriakidou, A; Georgiou, I; Kolaitis, N; Kolios, G; Michalis, LK; Naka, KK; Vakalis, KV | 1 |
| Ilhan, N; Kaman, D; Kucuksu, M; Ozbay, Y | 1 |
| Chen, YJ; Gau, CS; Hwang, JJ; Lin, YH; Lin, YL; Pao, KY; Tsai, IJ; Tsai, WS; Wu, VC; Yang, WS | 1 |
| Bolca, O; Cakmak, N; Nurkalem, Z; Onturk, E; Sahin, S; Sayar, N; Tangurek, B; Yilmaz, H; Yilmaz, M | 1 |
| Hardin-Fanning, F | 1 |
| Jacobsen, DW; Mayer, EL; Robinson, K | 1 |
| Chan, CF; Cheng, SK; Lolin, YI; Masarei, JR; Pang, CP; Sanderson, JE; Woo, KS | 1 |
| Grobbee, DE; Kok, FJ; Kruyssen, DA; Refsum, H; Schouten, EG; Ueland, PM; Verhoef, P; Witteman, JC | 1 |
| Blom, HJ; Kluijtmans, LA; Kok, FJ; Kruyssen, DA; Refsum, H; Ueland, PM; Verhoef, P | 1 |
| Nygård, O; Refsum, H; Ueland, PM; Vollset, SE | 1 |
| Kok, FJ; Siri, PW; Verhoef, P | 1 |
| Burgess, ED; Hyndman, ME; Manns, BJ; Parsons, HG; Schaefer, JP; Scott-Douglas, NW | 1 |
| Bostom, AG; Garber, C | 1 |
| Bulterjis, EJ; de Jong, SC; Jakobs, CA; Mackaay, AJ; Rauwerda, JA; Stehouwer, CD; Twisk, JW; van Campen, CM; van den Berg, M; Vermeulen, EG; Visser, FC | 1 |
| Robinson, K; Seshadri, N | 2 |
| Andrejak, M; Iannetta Peltier, MC; Lesbre, JP; Peltier, M; Tribouilloy, CM; Trojette, F | 1 |
| Kluijtmans, LA; Whitehead, AS | 1 |
| Abrams, J; Chai, AU | 1 |
| Auer, J; Berent, R; Eber, B; Lassnig, E; Weber, T | 1 |
| Bostom, AG; Jacques, PF; Liaugaudas, G; Rosenberg, IH; Selhub, J | 1 |
| Chen, J; Cheng, L; Li, Y; Zhang, I | 1 |
| Bacchi-Reggiani, L; Branzi, A; Falchetti, E; Grigioni, F; Magelli, C; Magnani, G; Mantovani, V; Potena, L; Sassi, S; Sorbello, S; Viggiani, M | 1 |
| SoRelle, R | 1 |
| Doshi, SN; Durrant, HJ; Goodfellow, J; Lewis, MJ; McDowell, IF; Moat, SJ; Payne, N | 1 |
| Bostom, AG | 1 |
| Födinger, M; Sunder-Plassmann, G | 1 |
| Pogach, L | 1 |
| Bourantas, K; Goudevenos, J; Katsouras, CS; Kolaitis, N; Loukas, S; Michalis, LK; Pappas, K; Sideris, DA; Tweddel, A | 1 |
| Barton, M; Haudenschild, CC | 1 |
| Lüscher, TF; Noll, G; Spieker, LE | 1 |
| Bostom, AG; Jacques, PF; Liaugaudas, G; Rogers, G; Rosenberg, IH; Selhub, J | 1 |
| Ben-Valid, E; Doncheva, M; el Wahab-Daraushe, A; Gefel, D; Lugassy, G; Sela, BA | 1 |
| Bagley, PJ; Choi, SW; Corrocher, R; Dolnikowski, GG; Friso, S; Girelli, D; Jacques, PF; Mason, JB; Olivieri, O; Rosenberg, IH; Selhub, J | 1 |
| Erdei, F; Katona, A; Kondacs, A; Mark, L; Markizay, J | 1 |
| Fujioka, T; Nasu, M; Tamura, A | 1 |
| Corrocher, R; Faccini, G; Friso, S; Girelli, D; Martinelli, N; Olivieri, O; Pignatti, PF; Stranieri, C; Tinazzi, E; Trabetti, E | 1 |
| Bialkowska, M; McCully, KS; Olszewski, AJ; Rudnicki, S; Szostak, WB | 1 |
19 review(s) available for folic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
Topics: Aged; Atherosclerosis; Brachial Artery; Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vasodilation | 2014 |
Nutritional factors in the prevention and management of coronary artery disease and heart failure.
Topics: Alprostadil; Anti-Inflammatory Agents; Arginine; CD59 Antigens; Coronary Artery Disease; Diabetes Mellitus, Type 2; Epoprostenol; Fatty Acids, Essential; Fatty Acids, Unsaturated; Female; Folic Acid; Heart Failure; Humans; Hypertension; Lipoxins; Magnesium; Male; Middle Aged; Nitric Oxide; Nutritional Status; Serum Albumin; Vasodilation; Vitamin B 12; Vitamin B 6 | 2015 |
Association between eNOS polymorphisms and risk of coronary artery disease in a Korean population: a meta-analysis.
Topics: Aged; Alleles; Asian People; Case-Control Studies; Comorbidity; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Homocysteine; Humans; Linkage Disequilibrium; Male; Middle Aged; Nitric Oxide Synthase Type III; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Republic of Korea; Risk; Risk Factors | 2015 |
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Topics: Clinical Trials as Topic; Coronary Artery Disease; Folic Acid; Food, Fortified; Homocysteine; Humans; Oxidation-Reduction; Vitamin B Complex; Vitamins | 2009 |
Folate gene polymorphisms MTR A2756G, MTRR A66G, and BHMT G742A and risk for coronary artery disease: a meta-analysis.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Betaine-Homocysteine S-Methyltransferase; Case-Control Studies; Coronary Artery Disease; Ferredoxin-NADP Reductase; Folic Acid; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Risk | 2012 |
Optimal diets for prevention of coronary heart disease.
Topics: Coronary Artery Disease; Diet; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Folic Acid; Humans; Life Style; Lipoproteins | 2002 |
[Homocysteine and coronary artery disease].
Topics: Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors | 2003 |
Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Clinical Trials as Topic; Coronary Artery Disease; Coronary Restenosis; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; ortho-Aminobenzoates; Oxidative Stress; Probucol; Sirolimus; Vitamins | 2003 |
Clinical inquiries. Is folate supplementation indicated for patients with CAD?
Topics: Coronary Artery Disease; Folic Acid; Hematinics; Homocysteine; Humans; Randomized Controlled Trials as Topic | 2004 |
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Angiography; Angioplasty, Balloon, Coronary; Antioxidants; Ascorbic Acid; Atherosclerosis; beta Carotene; Coronary Artery Disease; Dietary Supplements; Disease Progression; Female; Folic Acid; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selenium; Trace Elements; Ultrasonography, Interventional; Vitamin B 12; Vitamin B 6; Vitamin E; Vitamins | 2006 |
Preventing cardiovascular disease in women: an update.
Topics: Aspirin; Coronary Artery Disease; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Risk Factors; Sex Factors; United States | 2008 |
The effects of a Mediterranean-style dietary pattern on cardiovascular disease risk.
Topics: Antioxidants; Coronary Artery Disease; Diet, Mediterranean; Dietary Fiber; Fatty Acids, Unsaturated; Folic Acid; Humans | 2008 |
Homocysteine and coronary atherosclerosis.
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Homocystinuria; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 1996 |
Homocysteine and cardiovascular disease.
Topics: Arteriosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Female; Folic Acid; Folic Acid Deficiency; Forecasting; Homocysteine; Humans; Intracranial Arteriosclerosis; Male; Peripheral Vascular Diseases; Prevalence; Risk Factors; Safety; Thromboembolism; Vitamin B 12; Vitamin B 12 Deficiency | 1998 |
Homocysteine, B vitamins, and coronary artery disease.
Topics: Clinical Trials as Topic; Coronary Artery Disease; Folic Acid; Humans; Hyperhomocysteinemia; Myocardial Infarction; Recurrence; Risk Factors; Vitamin B Deficiency | 2000 |
Homocysteine and coronary risk.
Topics: Age Factors; Clinical Trials as Topic; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Life Style; Male; Risk Factors; Sex Factors | 1999 |
Homocysteine: a new cardiac risk factor?
Topics: Coronary Artery Disease; Coronary Disease; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Risk Factors | 2001 |
[Homocysteine and cardiovascular risk].
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Animals; Arteriosclerosis; Clinical Trials as Topic; Coronary Artery Disease; Disease Models, Animal; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Models, Biological; Vitamin B 12 | 2001 |
Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Aspirin; Biopterins; Calcium Channel Blockers; Coronary Artery Disease; Endothelins; Endothelium, Vascular; Folic Acid; Hormone Replacement Therapy; Humans; Nitrates; Nitric Oxide; Nitric Oxide Synthase | 2001 |
25 trial(s) available for folic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Topics: Coronary Artery Disease; Fibrin; Folic Acid; Homocysteine; Humans; Myocardial Infarction; Prognosis; Risk Factors; Thrombosis; Vitamin B 12; Vitamin B Complex | 2022 |
Randomized trial evaluating the effect of aged garlic extract with supplements versus placebo on adipose tissue surrogates for coronary atherosclerosis progression.
Topics: Aged; Arginine; Coronary Artery Disease; Coronary Vessels; Dietary Supplements; Disease Progression; Double-Blind Method; Female; Folic Acid; Garlic; Humans; Male; Middle Aged; Pericardium; Plant Extracts; Subcutaneous Fat; Vascular Calcification; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2018 |
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine.
Topics: Adenosine; Aged; Arginine; Coronary Angiography; Coronary Artery Disease; Disease Progression; Ethionine; Female; Folic Acid; Follow-Up Studies; Humans; Lysine; Male; Methylation; Middle Aged; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2013 |
Dietary intake of n-3 long-chain polyunsaturated fatty acids and risk of myocardial infarction in coronary artery disease patients with or without diabetes mellitus: a prospective cohort study.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus; Fatty Acids, Omega-3; Female; Fish Oils; Folic Acid; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Norway; Prospective Studies; Risk Factors; Seafood | 2013 |
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Association of oxidative stress, iron, and centralized fat mass in healthy postmenopausal women.
Topics: Aged; Biomarkers; Body Fat Distribution; Body Mass Index; Bone and Bones; Bone Density; Coronary Artery Disease; Double-Blind Method; Female; Ferritins; Folic Acid; Humans; Iron; Middle Aged; Oxidative Stress; Postmenopause; Reference Values; Soybean Proteins; Waist-Hip Ratio | 2009 |
Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy.
Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; Coronary Angiography; Coronary Artery Disease; Disease Progression; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Male; Middle Aged; Norway; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2010 |
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12.
Topics: Acetylcholine; Adenosine; Aged; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Laser-Doppler Flowmetry; Male; Middle Aged; Time Factors; Vitamin B 12; Vitamin B 6 | 2011 |
Secondary prevention with folic acid: effects on clinical outcomes.
Topics: Aged; Cholesterol; Coronary Artery Disease; Drug Therapy, Combination; Endothelium, Vascular; Female; Folic Acid; Follow-Up Studies; Hematinics; Homocysteine; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Outcome Assessment, Health Care; Time Factors; Triglycerides | 2003 |
Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemi
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Female; Folic Acid; Homocysteine; Humans; Intracranial Arteriosclerosis; Ischemia; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Vitamin B 12; Vitamin B 6 | 2003 |
Pharmacokinetic study on the utilisation of 5-methyltetrahydrofolate and folic acid in patients with coronary artery disease.
Topics: Aged; Biological Availability; Coronary Artery Disease; Cross-Over Studies; Female; Folic Acid; Humans; Male; Middle Aged; Tetrahydrofolates | 2004 |
Effect of homocysteine-lowering vitamin treatment on electrocardiography stress tests in a randomized, placebo-controlled trial: comparison between ST-segment changes and Athen QRS-score.
Topics: Coronary Artery Disease; Double-Blind Method; Electrocardiography; Exercise Test; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Middle Aged; Vitamin B 6 | 2004 |
Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Folic Acid; Homocysteine; Humans; Male; Mental Recall; Middle Aged; Single-Blind Method; Treatment Outcome; Vitamin B 12; Vitamin B 6 | 2004 |
High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease.
Topics: Adenosine; Aged; Blood Flow Velocity; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Regional Blood Flow; Vasodilation | 2005 |
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
Topics: Aged; Biomarkers; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Inflammation; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Pyridoxine; Vitamin B 12; Vitamins | 2005 |
Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
Topics: Aged; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Dehydrogenase (NAD+); Middle Aged; Models, Statistical; Placebos; Polymorphism, Genetic; Regression Analysis; Risk Factors; Singapore; Stroke; Vitamin B 12; Vitamin B 6; Vitamins | 2006 |
Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women.
Topics: Aged; Biomarkers; Body Mass Index; C-Reactive Protein; Coronary Artery Disease; Double-Blind Method; Female; Ferritins; Folic Acid; Homocysteine; Humans; Iron; Isoflavones; Lipids; Middle Aged; Oxidative Stress; Phytic Acid; Plant Proteins, Dietary; Postmenopause; Regression Analysis; Risk Factors; Soybean Proteins; Transferrin; Vitamin B 12 | 2006 |
High- but not low-dose folic acid improves endothelial function in coronary artery disease.
Topics: Aged; Betaine; Cardiotonic Agents; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Hematinics; Humans; Male; Middle Aged | 2006 |
Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease.
Topics: Aged; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Endothelium, Vascular; Female; Folic Acid; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Pulsatile Flow; Superoxides; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex | 2007 |
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; CD40 Ligand; Cholesterol, LDL; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Humans; Interleukin-6; Male; Middle Aged; Neopterin; Prospective Studies; Treatment Outcome; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2007 |
Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
Topics: Acetylcysteine; Administration, Oral; Aged; Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged | 2007 |
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
Topics: Blood Pressure; Coronary Artery Disease; Family; Female; Folic Acid; Hematinics; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Pyridoxine; Risk Factors | 2000 |
Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering.
Topics: Coronary Artery Disease; Double-Blind Method; Endothelium, Vascular; Female; Folic Acid; Hematinics; Homocysteine; Humans; Male; Middle Aged; Tetrahydrofolates; Time Factors; Treatment Outcome; Vasodilation | 2002 |
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Topics: Coronary Artery Disease; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Riboflavin; Vitamin B 6 | 2002 |
Effect of treatment with folic acid and vitamin B6 on lipid and homocysteine concentrations in patients with coronary artery disease.
Topics: Aged; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Genotype; Hematinics; Homocysteine; Humans; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Treatment Outcome; Vitamin B 6 | 2002 |
83 other study(ies) available for folic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Use of serum folate and vitamin B
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Prospective Studies; Vitamin B 12; Vitamin B 12 Deficiency; Vitamins | 2023 |
Circulating folate concentrations and risk of coronary artery disease: a prospective cohort study in Chinese adults and a Mendelian randomization analysis.
Topics: Adult; Aged; Asian People; China; Coronary Artery Disease; Female; Folic Acid; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Prospective Studies | 2020 |
Application and interpretation of Mendelian randomization approaches in exploring the causality between folate and coronary artery disease.
Topics: Adult; Asian People; Coronary Artery Disease; Folic Acid; Humans; Mendelian Randomization Analysis; Prospective Studies | 2020 |
Reply to P-F Wu et al.
Topics: Asian People; Coronary Artery Disease; Folic Acid; Humans; Mendelian Randomization Analysis; Prospective Studies | 2020 |
Probing the epigenetic signatures in subjects with coronary artery disease.
Topics: Adult; Biomarkers; Coronary Artery Disease; Correlation of Data; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Demography; Diabetes Mellitus; DNA Methylation; Epigenesis, Genetic; Female; Fibroblast Growth Factor 2; Folic Acid; Folic Acid Deficiency; Humans; Interleukin-6; Male; Middle Aged; Proteoglycans; Receptors, Thrombin; Receptors, Transforming Growth Factor beta; Regression Analysis; Risk Factors; Tumor Necrosis Factor-alpha | 2020 |
Long-term supplementation with folic acid and vitamin B-12 has no effect on circulating uric acid concentrations in Norwegian patients with coronary artery disease.
Topics: China; Coronary Artery Disease; Folic Acid; Humans; Norway; Primary Prevention; Stroke; Uric Acid; Vitamin B 12; Vitamins | 2018 |
Reply to J Dierkes et al.
Topics: Coronary Artery Disease; Folic Acid; Humans; Uric Acid; Vitamin B 12; Vitamins | 2018 |
Machine learning algorithm-based risk prediction model of coronary artery disease.
Topics: Adult; Aged; Algorithms; Case-Control Studies; Coronary Artery Disease; Cytochrome P-450 CYP1A1; Epistasis, Genetic; Female; Folic Acid; Forecasting; Genetic Predisposition to Disease; Glycine Hydroxymethyltransferase; Humans; Machine Learning; Male; Middle Aged; Multifactor Dimensionality Reduction; Polymorphism, Single Nucleotide; Risk Factors; Xenobiotics | 2018 |
Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Artery Disease; Dyslipidemias; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; India; Male; Middle Aged; Risk Factors; Vitamin B 12; Vitamin B 12 Deficiency | 2013 |
[A prospective study on the association of plasma homocysteine level with stroke in hypertensive patients].
Topics: Antihypertensive Agents; Coronary Artery Disease; Coronary Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hypertension; Incidence; Male; Prospective Studies; Socioeconomic Factors; Stroke | 2015 |
Folic Acid Attenuates Vascular Endothelial Cell Injury Caused by Hypoxia via the Inhibition of ERK1/2/NOX4/ROS Pathway.
Topics: Coronary Artery Disease; Cytoprotection; Folic Acid; Gene Expression Regulation, Enzymologic; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Reactive Oxygen Species | 2016 |
Homocysteine-reducing B vitamins and ischemic heart disease: a separate-sample Mendelian randomization analysis.
Topics: Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Mendelian Randomization Analysis; Middle Aged; Myocardial Infarction; Odds Ratio; Polymorphism, Single Nucleotide; Vitamin B 12; Vitamin B Complex | 2017 |
Serum high concentrations of homocysteine and low levels of folic acid and vitamin B
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; China; Coronary Artery Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Incidence; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Severity of Illness Index; Vitamin B 12 | 2017 |
High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
Topics: Alleles; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Asian; Black or African American; Coronary Artery Disease; Cystathionine beta-Synthase; Enzymes; Female; Ferredoxin-NADP Reductase; Folic Acid; Genotype; Hispanic or Latino; Homocysteine; Humans; Lupus Erythematosus, Systemic; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Predictive Value of Tests; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; White People | 2008 |
Effects of metoprolol and diltiazem on plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Artery Disease; Dilatation, Pathologic; Diltiazem; Female; Folic Acid; Homocysteine; Humans; Male; Metoprolol; Middle Aged; Treatment Outcome; Vitamin B 12 | 2009 |
Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease.
Topics: Aged; Aryldialkylphosphatase; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Vitamin B 12 | 2009 |
Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events.
Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Survival Rate; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2008 |
Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Case-Control Studies; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Methylmalonic Acid; Middle Aged; Polymorphism, Genetic; Risk Factors | 2010 |
Cardiac rehabilitation provides favourable long-term dietary changes. Why not extend the educational programme?
Topics: Ascorbic Acid; Biomarkers; Coronary Artery Disease; Counseling; Erythrocyte Membrane; Fatty Acids, Unsaturated; Feeding Behavior; Folic Acid; Health Knowledge, Attitudes, Practice; Humans; Lipids; Nutritional Status; Patient Compliance; Patient Education as Topic; Practice Guidelines as Topic; Risk Reduction Behavior; Time Factors; Treatment Outcome | 2009 |
Sustained positive impact of a coronary rehabilitation programme on adherence to dietary recommendations.
Topics: Adult; Ascorbic Acid; Biomarkers; Coronary Artery Disease; Counseling; Erythrocyte Membrane; Fatty Acids, Unsaturated; Feeding Behavior; Folic Acid; Health Knowledge, Attitudes, Practice; Humans; Lipids; Male; Middle Aged; Nutrition Assessment; Nutritional Status; Patient Compliance; Patient Education as Topic; Practice Guidelines as Topic; Program Evaluation; Risk Reduction Behavior; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2009 |
Association between asymmetric dimethylarginine and neopterin in patients with and without angiographic coronary artery disease.
Topics: Arginine; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Folic Acid; Homocysteine; Humans; Middle Aged; Neopterin; Risk Factors; Vitamin B 12; Vitamin B 6 | 2009 |
Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
Topics: Adult; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Survival Analysis; Treatment Outcome; Vitamin B Complex | 2009 |
Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers.
Topics: Aged; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Creatinine; Disease Progression; Female; Folic Acid; Homocysteine; Humans; Inflammation Mediators; Male; Middle Aged; Neopterin; Vitamin B 12 | 2010 |
Relationship between L-arginine/asymmetric dimethylarginine, homocysteine, folic acid, vitamin B levels, and coronary artery ectasia.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Dilatation, Pathologic; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Prospective Studies; Turkey; Vitamin B Complex | 2010 |
Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aryldialkylphosphatase; Case-Control Studies; Coronary Artery Disease; Cystathionine beta-Synthase; Epistasis, Genetic; Female; Folic Acid; Gene Frequency; Genetic Association Studies; Genotype; Homocysteine; Humans; INDEL Mutation; Logistic Models; Male; Metabolic Networks and Pathways; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2011 |
Gene polymorphisms and low dietary intake of micronutrients in coronary artery disease.
Topics: Aged; Case-Control Studies; Coronary Artery Disease; Disease Susceptibility; Eating; Female; Folic Acid; Folic Acid Deficiency; Gene Frequency; Genotype; Humans; Male; Micronutrients; Middle Aged; Polymorphism, Genetic; Risk Factors; Vitamin B Complex | 2011 |
Paradoxical role of C1561T glutamate carboxypeptidase II (GCPII) genetic polymorphism in altering disease susceptibility.
Topics: Abortion, Spontaneous; Antigens, Surface; Autistic Disorder; Breast Neoplasms; Cohort Studies; Coronary Artery Disease; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Glutamate Carboxypeptidase II; Humans; Male; Polymorphism, Genetic; Prostatic Neoplasms | 2012 |
Role of homocysteine & MTHFR C677T gene polymorphism as risk factors for coronary artery disease in young Indians.
Topics: Adult; Cholesterol; Coronary Artery Disease; Female; Folic Acid; Genetic Association Studies; Homocysteine; Humans; Hyperhomocysteinemia; India; Lipoproteins, HDL; Lipoproteins, LDL; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Smoking; Triglycerides; Vitamin B 12 | 2012 |
Oxidative stress in coronary artery disease: epigenetic perspective.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line; Coronary Artery Disease; Decitabine; DNA Methylation; Endothelial Cells; Epigenesis, Genetic; Female; Ferredoxin-NADP Reductase; Folic Acid; Glutathione S-Transferase pi; Glycine Hydroxymethyltransferase; Homocysteine; Humans; Hydroxamic Acids; Male; Malondialdehyde; Membrane Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidative Stress; Promoter Regions, Genetic; Protein Carbonylation; Proto-Oncogene Proteins; Superoxide Dismutase; Young Adult | 2013 |
Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromosome Segregation; Coronary Angiography; Coronary Artery Disease; Family; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Pedigree; Vitamin B 12 | 2002 |
Effect of implementation of folic acid fortification of food on homocysteine concentrations in subjects with coronary artery disease.
Topics: Aged; Biomarkers; Blood Pressure; C-Reactive Protein; Coronary Artery Disease; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Regression Analysis; Severity of Illness Index; Treatment Outcome | 2002 |
Homocysteine and other vascular risk factors in patients with phenylketonuria on a diet.
Topics: Child; Child, Preschool; Coronary Artery Disease; Diet, Protein-Restricted; Endothelin-1; Folic Acid; Homocysteine; Humans; Lipids; Nutrition Assessment; Phenylalanine; Phenylketonurias; Risk Factors; Vitamin B 12; Vitamin B 6 | 2002 |
Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors; Vitamin B 12 | 2003 |
The interaction between MTHFR 677 C-->T genotype and folate status is a determinant of coronary atherosclerosis risk.
Topics: Base Sequence; Coronary Artery Disease; Erythrocytes; Female; Folic Acid; Genetic Variation; Genotype; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Risk Factors | 2003 |
Serum homocysteine concentrations and their relation to serum folate and vitamin B12 concentrations and coronary artery disease prevalence in an urban, bi-ethnic community.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Hispanic or Latino; Homocysteine; Humans; Male; New Mexico; Prospective Studies; Risk Factors; Urban Health; Vitamin B 12; White People | 2003 |
[The use of vitamin B12 and folic acid in coronary atherosclerosis].
Topics: Coronary Artery Disease; Coronary Disease; Corrinoids; Folic Acid; Hematinics; Humans; Vitamin B 12; Vitamin B Complex | 1957 |
Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations.
Topics: Biomarkers; Cardiomyopathies; Coronary Artery Disease; Creatinine; Female; Florida; Folic Acid; Heart Failure; Heart Transplantation; Hematinics; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Oxygen Consumption; Pulmonary Wedge Pressure; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stroke Volume; Treatment Outcome | 2003 |
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Topics: Adult; Aged; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Cysteine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors; Threonine; Vitamin B 12 | 2003 |
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
Topics: Aged; Coronary Artery Disease; Coronary Restenosis; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postoperative Complications; Prosthesis Implantation; Stents; Thrombosis; Treatment Outcome; Vitamin B 12 | 2003 |
Hyperhomocysteinaemia & folic acid supplementation in patients with high risk of coronary artery disease.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Immunoassay; Male; Microscopy, Fluorescence; Middle Aged; Risk Factors; Time Factors; Vitamin B 12 | 2004 |
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
Topics: Aged; Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; DNA Primers; Female; Folic Acid; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Severity of Illness Index; Vitamin B 12 | 2004 |
Homocysteine and progression of coronary artery disease.
Topics: Adult; Blood Glucose; Coronary Artery Disease; Disease Progression; Folic Acid; Homocysteine; Humans; Hypertension; Lipids; Male; Middle Aged; Myocardial Infarction; Obesity; Research Design; Risk Factors; Smoking; Vitamin B 12 | 2004 |
Changes of homocysteine levels and arterial endothelial function in patients with high risk of coronary artery disease after 6-month folic acid supplementation.
Topics: Aged; Arteries; Chromatography, High Pressure Liquid; Coronary Artery Disease; Dietary Supplements; Endothelium, Vascular; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Factors; Time; Treatment Outcome; Vitamin B 12 | 2004 |
Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Coronary Artery Disease; Female; Folic Acid; Genotype; Homocysteine; Humans; Korea; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Nutritional Status; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Vitamin B 12 | 2006 |
Plasma homocysteine levels in patients with isolated coronary artery ectasia.
Topics: Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Dilatation, Pathologic; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Vitamin B 12 | 2005 |
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Brain Ischemia; C-Reactive Protein; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Female; Fibrinogen; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Life Style; Lipoprotein(a); Male; Risk Factors; Stroke; Time Factors; Triglycerides; von Willebrand Factor | 2005 |
The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Coronary Artery Disease; Cystathionine beta-Synthase; Environment; Erythrocytes; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Polymorphism, Genetic; Risk Factors; Vitamin B 12; Vitamin B 6 | 2005 |
Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Alleles; Case-Control Studies; Coronary Artery Disease; Female; Ferredoxin-NADP Reductase; Folic Acid; France; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Transcobalamins; Vitamin B 12; White People | 2005 |
Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Topics: Acute Disease; Adult; Aged; Blood Coagulation; Case-Control Studies; Coronary Artery Disease; Diabetes Mellitus; Drug Resistance; Fibrin; Fibrinolytic Agents; Folic Acid; Hematinics; Homocysteine; Humans; Hypercholesterolemia; Hyperhomocysteinemia; Male; Middle Aged; Permeability; Recombinant Proteins; Tissue Plasminogen Activator | 2006 |
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women.
Topics: Aged; Cardiovascular Diseases; Cohort Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Postmenopause; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Time Factors; White People | 2006 |
The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Topics: Aged; Cohort Studies; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Folic Acid; Gene Frequency; Heterozygote; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Peripheral Vascular Diseases; Polymorphism, Genetic; Risk Factors; Stroke; Vitamin B 12 | 2006 |
Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Reference Values; Tunica Intima; Tunica Media | 2006 |
[Homocysteine level, relationship with cardiovascular risk factors in selected Polish population].
Topics: Adult; Aged; Coronary Artery Disease; Environmental Monitoring; Epidemiological Monitoring; Female; Folic Acid; Health Status; Homocysteine; Humans; Life Style; Male; Middle Aged; Poland; Risk Factors; Rural Population; Smoking; Urban Population; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2005 |
Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.
Topics: Adult; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Male; Prevalence; Risk Factors; Sex Characteristics; Vitamin B 12; Vitamin B 12 Deficiency | 2006 |
Circulating homocysteine levels in patients with type 2 diabetes mellitus.
Topics: Aged; Blood Glucose; Coronary Angiography; Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Folic Acid; Genotype; Glomerular Filtration Rate; Glycated Hemoglobin; Homocysteine; Humans; Linear Models; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Polymorphism, Genetic; Up-Regulation; Vitamin B 12 | 2008 |
[In patients with coronary artery disease and left ventricular contractile insufficiency the pathogenicity of smoking associates with imbalance in metabolism of homocysteine].
Topics: Adult; Comorbidity; Coronary Angiography; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2006 |
Homocysteine (Hcy) follow-up study.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Coronary Artery Disease; Enzyme-Linked Immunosorbent Assay; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Vitamin B 12; Vitamin B Complex | 2007 |
Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Biomarkers; Coronary Artery Disease; Erythrocytes; Female; Folic Acid; Folic Acid Deficiency; Genetic Predisposition to Disease; Humans; Male; Membrane Transport Proteins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Serum | 2008 |
The 677 C/T MTHFR polymorphism is associated with essential hypertension, coronary artery disease, and higher homocysteine levels.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Genetic; Risk Factors; Turkey; Vitamin B 12 | 2008 |
Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease.
Topics: Aged; Biomarkers; Body Mass Index; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Obesity; Risk Factors; Vitamin B 12; Waist-Hip Ratio | 2008 |
Hyperhomocysteinaemia and premature coronary artery disease in the Chinese.
Topics: Adult; Case-Control Studies; China; Cholesterol; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Hong Kong; Humans; Male; Middle Aged; Prevalence; Risk Factors; Smoking; Vitamin B 12 | 1996 |
Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis.
Topics: Adult; Aging; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Erythrocytes; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Pyridoxal Phosphate; Risk Factors; Sex Characteristics; Vitamin B 12; Vitamin B Complex | 1997 |
The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease.
Topics: Adult; Aged; Alcohol Drinking; Case-Control Studies; Comorbidity; Coronary Artery Disease; Disease Susceptibility; Erythrocytes; Fasting; Female; Folic Acid; Genes; Genotype; Homocysteine; Humans; Hyperlipidemias; Hypertension; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Obesity; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Risk Factors; Smoking | 1997 |
Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.
Topics: Adult; Aged; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Pyridoxine; Regression Analysis; Risk Factors; Vitamin B 12 | 1998 |
Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Topics: Aged; Arteriosclerosis; Coronary Artery Disease; Cross-Sectional Studies; Erythrocytes; Female; Folic Acid; Homocysteine; Homocystine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Renal Dialysis; Retrospective Studies; Risk Factors; Sex Factors; Vitamin B 12 | 1999 |
Endpoints for homocysteine-lowering trials.
Topics: Adult; Aged; Child; Coronary Artery Disease; Folic Acid; Hematinics; Humans; Hyperhomocysteinemia; Pyridoxine | 2000 |
Plasma homocysteine and severity of thoracic aortic atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Biomarkers; Cholesterol; Coronary Artery Disease; Cross-Sectional Studies; Echocardiography, Transesophageal; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Vitamin B 12 | 2000 |
Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk.
Topics: Coronary Artery Disease; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases Acting on CH-NH Group Donors | 2001 |
Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour.
Topics: Adult; Aged; Coronary Artery Disease; Coronary Disease; Creatinine; Edible Grain; Female; Flour; Folic Acid; Food, Fortified; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Renal Insufficiency; Risk Factors; Vitamin B 12 | 2001 |
The effect of polymorphisms of MTHER gene and vitamin B on hyperhomocysteinemia.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Point Mutation; Polymorphism, Restriction Fragment Length; Vitamin B 12 | 2001 |
Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients.
Topics: Adult; Aged; Coronary Artery Disease; Female; Folic Acid; Genotype; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Function Tests; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Postoperative Complications; Prognosis; Risk Factors | 2001 |
Folate reduces homocysteine levels and lowers rate of restenosis.
Topics: Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Secondary Prevention; Stents | 2001 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease.
Topics: Coronary Artery Disease; Cost-Benefit Analysis; Dietary Supplements; Folic Acid; Homocysteine; Humans; Vitamins | 2002 |
Relatively low red cell folate levels and acute coronary syndromes.
Topics: Acute Disease; Cholesterol, HDL; Coronary Artery Disease; Erythrocytes; Folic Acid; Humans; Male; Predictive Value of Tests; Regression Analysis; Smoking; Syndrome; Vitamin B 12 | 2001 |
Endothelium and atherogenesis: endothelial therapy revisited.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Endothelin-1; Endothelium, Vascular; Folic Acid; Macrophages; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors | 2001 |
Recurrent stroke in a young patient with celiac disease and hyperhomocysteinemia.
Topics: Adult; Celiac Disease; Coronary Artery Disease; Ferrous Compounds; Folic Acid; Folic Acid Deficiency; Hematinics; Humans; Hyperhomocysteinemia; Male; Recurrence; Stroke | 2002 |
A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.
Topics: Adult; Aged; Coronary Artery Disease; DNA Methylation; Female; Folic Acid; Genotype; Homozygote; Humans; Male; Mass Spectrometry; Methylenetetrahydrofolate Dehydrogenase (NAD+); Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Models, Statistical; Mutation; Oxidoreductases; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic | 2002 |
Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Female; Folic Acid; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Malabsorption Syndromes; Male; Middle Aged; Risk Factors; Vitamin B 12 | 2002 |
A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism.
Topics: Aged; Coronary Artery Disease; Female; Folic Acid; Gene Frequency; Homocysteine; Humans; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors | 2002 |
Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis.
Topics: Adult; Anticoagulants; Choline; Coronary Artery Disease; Coronary Disease; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hydroxyethylrutoside; Lipids; Male; Middle Aged; Pyridoxine; Riboflavin; Vitamin B 12 | 1989 |